202 related articles for article (PubMed ID: 6279206)
41. Inhibitors of angiotensin-converting enzyme.
Cushman DW; Ondetti MA; Cheung HS; Antonaccio MJ; Murthy VS; Rubin B
Adv Exp Med Biol; 1980; 130():199-225. PubMed ID: 6250340
[No Abstract] [Full Text] [Related]
42. Structure of human carboxypeptidase N (kininase I).
Skidgel RA; Weerasinghe DK; Erdös EG
Adv Exp Med Biol; 1989; 247A():325-9. PubMed ID: 2603798
[No Abstract] [Full Text] [Related]
43. Prolyl carboxypeptidase: a forgotten kidney angiotensinase. Focus on "Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry".
Velez JC
Am J Physiol Cell Physiol; 2013 May; 304(10):C939-40. PubMed ID: 23552286
[No Abstract] [Full Text] [Related]
44. Protracted effect of converting-enzyme inhibition on the rat's response to intraarterial bradykinin.
Lindsey CJ; de Paula UM; Paiva AC
Hypertension; 1983; 5(6 Pt 3):V134-7. PubMed ID: 6317554
[TBL] [Abstract][Full Text] [Related]
45. [Myocardial contractile function in experimental renovascular hypertension with a varying hemodynamic structure].
Stroganova NP
Fiziol Zh (1978); 1979; 25(1):23-9. PubMed ID: 421927
[No Abstract] [Full Text] [Related]
46. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
47. Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.
Messadi E; Vincent MP; Griol-Charhbili V; Mandet C; Colucci J; Krege JH; Bruneval P; Bouby N; Smithies O; Alhenc-Gelas F; Richer C
FASEB J; 2010 Dec; 24(12):4691-700. PubMed ID: 20667972
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulation.
Snyder RA; Wintroub BU
Biochim Biophys Acta; 1986 May; 871(1):1-5. PubMed ID: 3008847
[TBL] [Abstract][Full Text] [Related]
49. Interaction between the renin-angiotensin and beta adrenergic nervous systems in drinking and pressor responses after renal artery constriction.
Atkinson J; Lüthi P; Péra-Bally R; Peters-Haefeli L
J Pharmacol Exp Ther; 1982 May; 221(2):453-60. PubMed ID: 6281416
[TBL] [Abstract][Full Text] [Related]
50. Effects of variations in sodium intake on the acute vasodepressor response to kininase II inhibition in rats with mild two-kidney, one-clip hypertension.
Kushiro T; Lee TC; Girolami JP; Gassia JP; Maxwell MH
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():175s-178s. PubMed ID: 6256111
[TBL] [Abstract][Full Text] [Related]
51. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
[TBL] [Abstract][Full Text] [Related]
53. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
[TBL] [Abstract][Full Text] [Related]
54. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
Kabour A; Henegar JR; Devineni VR; Janicki JS
Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
[TBL] [Abstract][Full Text] [Related]
55. A study of kininase activity in pig liver [proceedings].
Sharma RK; Dearnley CN; Bailey GS
Biochem Soc Trans; 1979 Oct; 7(5):1061-3. PubMed ID: 556229
[No Abstract] [Full Text] [Related]
56. Changes in angiotensin converting enzyme activity in the renal vascular bed of streptozotocin-induced diabetic rat.
Kamata K; Mizutani K
Res Commun Mol Pathol Pharmacol; 1999; 104(2):181-92. PubMed ID: 10634311
[TBL] [Abstract][Full Text] [Related]
57. Physiologic role of the peripheral enkephalinergic system in regulating cardiovascular homeostasis: evidence of interactions with the renin-angiotensin and kallikrein-kinin systems.
Carmignani M; Porcelli G; Volpe AR; Preziosi P
Adv Exp Med Biol; 1989; 247B():477-81. PubMed ID: 2558518
[TBL] [Abstract][Full Text] [Related]
58. Inhibitors of kininases.
Erdös EG
Fed Proc; 1979 Dec; 38(13):2774-7. PubMed ID: 228988
[No Abstract] [Full Text] [Related]
59. [Vasomotor response of microscopic vessels of hypertensive rats to sudden drop of blood pressure induced by depressive substances (author's transl)].
Vacek L; Bravený P; Máchová L
Bratisl Lek Listy; 1980 Nov; 74(5):526-31. PubMed ID: 7448588
[No Abstract] [Full Text] [Related]
60. Angiotensin-converting enzyme: effect of antienzyme antibody in vivo.
Caldwell PR; Wigger HJ
FEBS Lett; 1976 Mar; 63(1):82-4. PubMed ID: 177313
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
